07/30/2026 | Press release | Distributed by Public on 07/30/2026 15:16
Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
| Lupin Pharma Canada Ltd. | Femyso Mifepristone 200 mg / Misoprostol 200 mcg tablet | DIN 02560569 | Kit, Tablet | Mifepristone 200 mg / Misoprostol 200 mcg | NR02557A |
Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Depth of recall: Retailers
Lupin Pharma Canada Limited.
550-1111 rue St-Charles Ouest
Longueuil, QC, J4K 5G4
Receive emails about new and updated recall and safety alerts.